Oticon Medical today announced that the US Food and Drug Administration (FDA) has granted premarket approval (PMA) to the company’s Neuro System to treat individuals 18 years or older, with bilateral ...
SOLANA BEACH, CALIFORNIA / ACCESS Newswire / October 1, 2025 / ClearPoint Neuro, Inc. (Nasdaq:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise ...
Scientists at Rutgers have developed a smart drug delivery system that targets inflammation in damaged nerves and helps treat spinal cord injuries and other neurological diseases. The method utilizes ...
SOMERSET, N.J.--(BUSINESS WIRE)--Oticon Medical today announced that the US Food and Drug Administration (FDA) has granted premarket approval (PMA) to the company’s Neuro System to treat individuals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results